Effect of abrupt discontinuation of high glucose infusion rates during parenteral nutrition

Related Experiment Videos

S L Werlin1, D Wyatt, B Camitta

  • 1Department of Pediatrics, Medical College of Wisconsin, Milwaukee 53226.

Insights

Discontinuing total parenteral nutrition abruptly is safe for most children over 2 years old. Glucose and insulin levels stabilized quickly without hypoglycemia, indicating a safe transition for pediatric patients.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Nutritional Support

Background:

  • Total parenteral nutrition (TPN) is a critical intervention for children unable to receive adequate nutrition orally or enterally.
  • The metabolic and hormonal responses to the abrupt cessation of TPN in pediatric patients require further elucidation.
  • Establishing safe protocols for TPN discontinuation is essential for optimizing patient care and transition to alternative feeding methods.

Purpose of the Study:

  • To evaluate the safety and metabolic impact of abruptly discontinuing total parenteral nutrition in children older than 2 years.
  • To assess serum glucose and insulin level dynamics following TPN cessation.
  • To identify factors that may influence the safety of TPN discontinuation.

Main Methods:

  • Serum glucose and insulin levels were measured in 15 children over 2 years of age.
  • Measurements were taken for 30 minutes after the abrupt discontinuation of total parenteral nutrition.
  • Clinical assessment for hypoglycemia symptoms and biochemical confirmation were performed.

Main Results:

  • Initially elevated insulin levels normalized rapidly post-TPN discontinuation.
  • Serum glucose levels remained stable within 15 minutes after cessation of TPN.
  • No instances of biochemical or symptomatic hypoglycemia were observed in any participant.
  • Factors such as glucose infusion rate, patient age, and steroid therapy did not appear to influence outcomes.

Conclusions:

  • Abrupt discontinuation of total parenteral nutrition is a safe procedure for the majority of pediatric patients older than 2 years.
  • The observed rapid normalization of insulin and stable glucose levels suggest effective metabolic adaptation.
  • These findings support the clinical practice of safely transitioning children off TPN without gradual tapering in most cases.

Related Concept Videos